Cognitive Enhancement in Bipolar Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Bipolar Disorder
Interventions
DRUG

pramipexole

po pramipexole versus matching placebo minimum 0.125 mg bid and maximum 0.75 mg bid

Trial Locations (1)

11004

North Shore - Long Island Jewish Health System, Glen Oaks

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Northwell Health

OTHER